1nKemia IUCT Group, S.A.

IKM

ES0156303002

Pharmaceuticals

Market Closed - BME Other stock markets 15:00:19 23/05/2024 BST			5-day change	1st Jan Change
0.31 ^EUR	0.00%		0.00%	0.00%

04-30	1nKemia IUCT Group, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
2020	Crescent Hill Capital Corporation cancelled the acquisition of unknown stake in 1nKemia IUCT Group, S.A..	CI

1nKemia IUCT Mulls Acquisitions

October 09, 2013 at 05:00 am

1nKemia IUCT Group, S.A. (CATS:IKM) is seeking acquisitions. 1nKemia looks acquire stakes in sector players and create synergies in the future.

Latest news about 1nKemia IUCT Group, S.A.

1nKemia IUCT Group, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	04-30	CI
Crescent Hill Capital Corporation cancelled the acquisition of unknown stake in 1nKemia IUCT Group, S.A..	18/07/20	CI
Unknown buyer acquired unknown stake in Leanbio SL from 1nKemia IUCT Group, S.A. for €0.32 million.	05/12/19	CI
An undisclosed buyer acquired Institut Univ. de Ciència i Tecnología, S.A from 1nKemia IUCT Group, S.A..	26/09/19	CI
Crescent Hill Capital Corporation signed an letter of intent to acquire unknown stake in 1nKemia IUCT Group, S.A..	18/07/19	CI
An unknown buyer acquired Joaquin Riera Tuebols S.A. and Laboratorio Micro-Bios, S.L. from 1nKemia IUCT Group, S.A. for €0.1 million.	28/06/19	CI
Phyture Biotech S.L. announced that it has received €0.61 million in funding from 1nKemia IUCT Group, S.A.	28/10/17	CI
Phyture Biotech S.L. announced that it expects to receive €0.55 million in funding from 1nKemia IUCT Group, S.A.	29/07/17	CI
Arkyne Technologies announced that it has received €0.25 million in funding from 1nKemia IUCT Group, S.A., Escola Sant Gervasi, SCCL, and other investors	27/12/16	CI
1nKemia IUCT Group, S.A. acquired 27% stake in Barcelona Ciencia Capilar for € 0.02 million.	20/06/16	CI
1nKemia IUCT Group, S.A. announced that it expects to receive €3.8 million in funding	14/06/16	CI
1nkemia Reportedly Seeking To Sell UK unit	06/06/16	CI
1nKemia IUCT Group, S.A. cancelled the acquisition of Labsa, S.L.	30/09/15	CI
1nKemia IUCT Group, S.A. entered into an agreement to acquire Laboratorio de Seguridad Alimentaria.	30/09/14	CI
Inkemia Opens Brazilian Subsidiary 'Inkemia IUCT Group Tecnologia'	01/05/14	CI
Inkemia Plans to Open Subsidiary in Brazil in 2014	09/12/13	CI
1nKemia IUCT Mulls Acquisitions	09/10/13	CI
InKemia IUCTgroup S.A. announced that it has received €2.50 million in funding.	07/08/13	CI
InKemia IUCTgroup S.A. announced that it expects to receive €2.50 million in funding.	25/04/13	CI
1Nkemia IUCT Group, SA has completed an IPO in the amount of €1.30 million.	06/12/12	CI
1Nkemia IUCT Group, SA has filed an IPO in the amount of €1.30 million.	26/11/12	CI

Chart 1nKemia IUCT Group, S.A.

Duration

Period

More charts

Inkemia IUCT Group SA is a Spain-based company primarily specialized in the biotechnological sector. The Company provides products and services for chemical, pharmaceutical, biopharmaceutical, life science and related industry. The Companyâs activity is related to the generation, promotion, development and sale of products and services. The Company transforms its knowledge and know-how into a pipeline of products, processes, services and technological platforms. Its solutions are specialized, integrated and protected by patents. The main areas of expertise are related to drugs development, industrial biotechnology and green chemistry. The Company has a number of subsidiaries, including IUCT SA and IUCT Empren SL.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
1NKEMIA IUCT GROUP, S.A.	0.00%	9.04M
CSL LIMITED	-2.24%	89.22B
SAMSUNG BIOLOGICS CO.,LTD.	+1.32%	40.49B
BIOGEN INC.	-15.73%	32.79B
UCB	+64.13%	26.23B
BIOMARIN PHARMACEUTICAL INC.	-21.28%	14.52B
INCYTE CORPORATION	-8.50%	13.09B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-44.07%	11.6B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-13.06%	11.5B
SWEDISH ORPHAN BIOVITRUM AB	+4.94%	8.82B